Clinical Trials

Clinical Trials

Clinical Trials at LCMH

 

Little Company of Mary Hospital, in participation with SWOG, is offering a clinical trial to breast cancer patients. SWOG is a worldwide network of researchers that design and conduct cancer clinical trials. The group's goal is to change medical practice so it improves the lives of people with cancer. SWOG trials test new ways to diagnose and treat cancer, as well as prevent it. SWOG researchers also study ways to improve the care cancer patients receive, and improve quality of life for both patients and survivors.

 

Clinical Trial:

  1. S1207   

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer. e^3 Breast Cancer Study-Evaluating Everolimus with Endocrine Therapy.

 

  1.  A011401         

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

 

  1. A011502          

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial

             

 

 

These are all the trials open at LCMH.

 

 

 

Principal Investigator:

Bassel M. Atassi, MD Hematologist / Oncologist at LCMH

 

For more information or to learn about openings, contact:

Vanessa Brown

Clinical Research Coordinator at LCMH

708-229-5547

Schedule Online Schedule Online Classes & EventsRecent News
What they're saying...